Research scientist
National Center for Advancing Translational Sciences
Dr. Yi-Han Lin is a biologist in the Division of Preclinical Innovation at the National Center for Advancing Translational Sciences, NIH. Her work focuses on development, optimization, and implementation of biochemical and cell-based high-throughput assays to small molecule screenings in different disease bases. She also works on mechanism of action studies of lead molecules and uses high-content imaging, mass spectrometry, and different activity assays to characterize targets. Prior to joining NCATS in 2021, Lin was a staff scientist at J. Craig Venter Institute, where she used quantitative proteomics for biomarker discovery in infectious diseases such as Streptococcus and Influenza infection, and acute kidney injury. Lin completed her postdoctoral training at Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, where she studied post-translational modifications at the host-pathogen interface. Lin obtained her Ph.D. in Chemistry from Emory University, and her B.S. in Chemistry from National Taiwan University.